Popular
Practical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases
Virtual EventPractical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases
April 08, 2026
08:00 PM - 09:00 PM EDT
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
CME/CEChairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
CME/CEProgress in Breast Cancer Care: Translating SABCS Data Into Practice
Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA
Medical Industry FeatureTreating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA
From Pixels to Practice: Advancing HCM Care With Multimodality Imaging
CME/CEFrom Pixels to Practice: Advancing HCM Care With Multimodality Imaging
Programs
Practical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases
Virtual EventPractical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases
April 08, 2026
08:00 PM - 09:00 PM EDT
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Project Oncology®Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Insights for Postmenopausal Osteoporosis Patients at Very High Risk of Fracture
Medical Industry FeatureInsights for Postmenopausal Osteoporosis Patients at Very High Risk of Fracture
Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event
MinuteCE®Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event
From Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma
CME/CEFrom Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma
The Burden of Cognitive Dysfunction in Multiple Sclerosis
NeuroFrontiersThe Burden of Cognitive Dysfunction in Multiple Sclerosis
Clinical Practice
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
CME/CEChairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
CME/CENavigating Treatment Sequencing After Frontline Treatment Failure in CLL
How Early Decisions in Upper GI Cancer Shape Long-Term Outcomes
Project Oncology®How Early Decisions in Upper GI Cancer Shape Long-Term Outcomes
Advancing Care in HNSCC: Evolving Strategies Across the Disease Continuum
CME/CEAdvancing Care in HNSCC: Evolving Strategies Across the Disease Continuum
GDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?
CME/CEGDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?
"We have tools that can think alongside us and free us from a lot of burdens," says Dr. Raja-Elie Abdulnour from NEJM Clinician
The Convergence"We have tools that can think alongside us and free us from a lot of burdens," says Dr. Raja-Elie Abdulnour from NEJM Clinician
Doctors Lounge
Next-Gen Clinical Monitoring: Predicting Inpatient Decline with AI-Driven Alerts
The ConvergenceNext-Gen Clinical Monitoring: Predicting Inpatient Decline with AI-Driven Alerts
Death by Planet? Strange Diagnoses from 1632 London’s Medical Records
Rub Some Dirt In ItDeath by Planet? Strange Diagnoses from 1632 London’s Medical Records
Disparities in Osteoporosis Care: Addressing Screening and Treatment Barriers
On the Frontlines of OsteoporosisDisparities in Osteoporosis Care: Addressing Screening and Treatment Barriers
Artificial Intelligence in Dermatology: Exploring New Diagnostic Strategies
Clinician's RoundtableArtificial Intelligence in Dermatology: Exploring New Diagnostic Strategies
Messy Labs, Major Breakthroughs: The Happy Accidents That Shaped Modern Medicine
Rub Some Dirt In ItMessy Labs, Major Breakthroughs: The Happy Accidents That Shaped Modern Medicine
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
On the Frontlines of Multiple SclerosisUncovering Disparities in Teleneurology Utilization Post-Pandemic
CME
Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice
MinuteCE®Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice
When GDMT Isn’t Enough: Understanding Residual Risk in Patients with HFrEF
MinuteCE®When GDMT Isn’t Enough: Understanding Residual Risk in Patients with HFrEF
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CEA Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CEPatient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
MinuteCE®GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
Industry Feature
Latest TROP2 ADC Approval for HR+ HER2- Metastatic Breast Cancer
Medical Industry FeatureLatest TROP2 ADC Approval for HR+ HER2- Metastatic Breast Cancer
Amyloid and Tau in Alzheimer’s Disease: Insights into Disease Progression
Medical Industry FeatureAmyloid and Tau in Alzheimer’s Disease: Insights into Disease Progression
Challenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care
Medical Industry FeatureChallenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care
Anti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation
Medical Industry FeatureAnti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation